Evidence map›Paper›PMID 38163895›Full record

ArticleEye and vision (London, England)2024

Assessing progression limits in different grades of keratoconus from a novel perspective: precision of measurements of the corneal epithelium.

Rui Ning, Yiran Wang, Zhenyu Xu, Ingemar Gustafsson, Jiawei Li, Giacomo Savini, Domenico Schiano-Lomoriello, Yichen Xiao, Aodong Chen, Xiaoying Wang and 2 more

Abstract read
In one paragraph

Article in Eye and vision (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rui Ning *Eye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Yiran Wang *Eye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Zhenyu Xu *Eye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Ingemar GustafssonDepartment of Clinical Sciences, Ophthalmology, Lund University, Skåne University Hospital, Malmö, Sweden.
Jiawei LiEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Giacomo SaviniIRCCS Bietti Foundation, Rome, Italy.
Domenico Schiano-LomorielloIRCCS Bietti Foundation, Rome, Italy.
Yichen XiaoEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Aodong ChenEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Xiaoying WangEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China.
Xingtao ZhouEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China. doctzhouxingtao@163.com.
Jinhai HuangEye Institute and Department of Ophthalmology and Vision Science, Institute for Medical and Engineering Innovation, Eye and ENT Hospital, Fudan University, N No.19 Baoqing Road, Xuhui District, Shanghai, 200031, China. jinhaihuang@fudan.edu.cn.ORCID http://orcid.org/0000-0001-9952-3175

Funding

Clinical Research Plan of SHDC SHDC2020CR1043BEYE & ENT Hospital of Fudan University High-level Talents Program 2021318Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning TP2022046Project of Shanghai Xuhui District Science and Technology 2020-015Shanghai Science and Technology 22S11900200Shanghai Science and Technology 23XD1420500the Project of National Natural Science Foundation of China 82271048
6 · The paper itself

Abstract

backgroundTo assess repeatability and reproducibility of corneal epithelium thickness (ET) measured by a spectral-domain optical coherence tomographer (SD-OCT)/Placido topographer (MS-39, CSO, Florence, Italy) in keratoconus (KC) population at different stages, as well as to determine the progression limits for evaluating KC progression.

methodsA total of 149 eyes were enrolled in this study, with 29 eyes in the forme fruste keratoconus (FFKC) group, 34 eyes in the mild KC group, 40 eyes in the moderate KC group, and 46 eyes in the severe KC group. Employing the within-subject standard deviation (S

resultsThe repeatability and reproducibility of MS-39 in patients with KC were acceptable, according to ICC values ranging from 0.732 to 0.954. However, patients with more severe KC and progressive peripheralization of the measurement points had higher TRTs but a thinning trend. The current study tended to set the cut-off values of mild KC, moderate KC, and severe KC to 4.9 µm, 5.2 µm, and 7.4 µm for thinnest epithelium thickness (TET). When differences between follow-ups are higher than those values, progression of the disease is possible. As for center epithelium thickness (CET), cut-off values for mild KC, moderate KC, and severe KC should be 2.8 µm, 4.4 µm, and 5.3 µm. This might be useful in the follow-up and diagnosis of keratoconus.

conclusionsThis study demonstrated that the precision of MS-39 was reduced in measuring more severe KC patients and more peripheral corneal points. In determining disease progression, values should be differentiated between disease-related real changes and measurement inaccuracies. Due to the large difference in ET measured by MS-39 between various stages of disease progression, it is necessary to accurately grade KC patients to avoid errors in KC clinical decision-making.

Indexed as

Corneal epithelium thicknessKeratoconusPrecisionProgression limits

Identifiers

PMID38163895
PMCPMC10759576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.